AwardedPRTGoods€727,088
261G000469 - INFLIximab 100 MG INJ BIOSSIMILAR (ZESSLY)
- Published
- Published 5 May 2026
Overview
Unidade Local de Saúde Santa Maria procured Infliximab 100 mg injection biosimilar (Zessly) for a value of 727,088 EUR. The contract was awarded to SANDOZ FARMACEUTICA, LDA on 22 April 2026.
Key details
- Country
- PRT
- Status
- Awarded
- Category
- Goods
- Estimated value
- €727,088
- Procedure
- Selective
- Published
- 5 May 2026
Antineoplastic and immunomodulating agents
Award outcome
- Awarded value
- €727,088
- Award date
- 22 April 2026
- Contract period
- — → 18 December 2026
- SANDOZ FARMACEUTICA, LDA
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
5 May 2026
Contracting authority
Unidade Local de Saúde Santa Maria, E.P.E.
Procuring entityLisboa, PRT
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.